Considerations in Paediatric and Adolescent Inflammatory Bowel Disease

Area of Science:

• Pediatric Gastroenterology
• Immunology
• Genetics

Background:

• Inflammatory bowel disease (IBD) incidence is rapidly increasing in children and adolescents.
• Pediatric-onset IBD typically presents with more severe and extensive disease compared to adult-onset IBD.
• Early screening for genetic and immunological disorders is crucial for effective management of pediatric IBD.

Purpose of the Study:

• To highlight the unique challenges and knowledge gaps in pediatric IBD.
• To emphasize the need for early and effective treatment strategies in pediatric IBD.
• To advocate for accelerated drug approvals and improved care transitions for young IBD patients.

Main Methods:

• Review of current literature on pediatric IBD management and treatment.
• Analysis of therapeutic approaches including exclusive enteral nutrition and dietary interventions.
• Discussion of biological therapies and challenges in drug approval for pediatric populations.

Main Results:

• Exclusive enteral nutrition is an effective induction therapy for pediatric Crohn's disease.
• Dietary therapies like the Crohn's disease exclusion diet show promise.
• Anti-tumour necrosis factor (TNF) therapy is the only approved biologic for pediatric IBD, with others used off-label.

Conclusions:

• Urgent need for additional treatment options and faster drug approvals in pediatric IBD.
• Improved transition care from pediatric to adult services is associated with better outcomes.
• Addressing knowledge gaps in etiology, diagnostics, treatment tailoring, and psychosocial support is critical for high-quality pediatric IBD care.